Mia's Feed
Medical News & Research

US Issues Recall of Shrimp Due to Radioactivity Concerns

US Issues Recall of Shrimp Due to Radioactivity Concerns

Share this article

U.S. health authorities have recalled shrimp imported from Indonesia due to potential contamination with radioactive cesium-137, emphasizing food safety concerns and the importance of monitoring imported seafood.

2 min read

In an important public health update, U.S. authorities have announced the recall of certain frozen shrimp products over concerns related to potential radioactivity contamination. The recall implicates shrimp imported from Indonesia, specifically from a company named PT. Bahari Makmur Sejati. These products have been distributed across 13 states through retail giant Walmart.

The issue came to light after the detection of the radioactive isotope cesium-137 in some of the imported shrimp. While the levels of radioactivity found were minimal and posed no immediate health hazard, the Food and Drug Administration (FDA) emphasized the importance of caution. The agency clarified that none of the shrimp currently available in U.S. stores tested positive for radioactivity; however, the concern lies with the condition in which the shrimp was processed, packed, or stored.

Officials indicated that the shrimp may have been subjected to insanitary conditions that led to contamination, raising longer-term safety questions. Chronic exposure to low doses of cesium-137 has been associated with an increased risk of developing cancer over time.

In response, the FDA has urged Walmart to stage a recall and advised consumers who purchased the affected shrimp to dispose of it properly. Although the contamination levels are low, the recall underlines the importance of food safety monitoring in imported seafood.

This recall highlights the need for rigorous safety checks in the seafood supply chain and serves as a reminder for consumers to remain vigilant about the origins of their seafood products. For more details, visit source.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Evolocumab Shows No Benefit in Preventing Vein Graft Disease After Coronary Bypass Surgery, Major Trial Finds

A recent trial reveals that evolocumab, despite significantly lowering LDL cholesterol, does not reduce vein graft disease rates after coronary artery bypass surgery, pointing to the need for novel treatment strategies.

Can Ozempic Help Lower Your Risk of Dementia?

Emerging research suggests that the diabetes medication Ozempic may help reduce the risk of developing dementia, offering hope for high-risk populations through metabolic and anti-inflammatory benefits.

Enhancing Road Safety Through Shared Responsibility and Innovation

A comprehensive approach involving shared responsibility and technological innovation is vital to reducing roadway fatalities and creating safer transportation systems for all road users.